Search
Now showing items 1-4 of 4
A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls.
(Arthritis Res Ther, 2016-04-12)
BACKGROUND: RA and CVD both have inflammation as part of the underlying biology. Our
objective was to explore the relationships of GlycA, a measure of glycosylated acute
phase proteins, with inflammation and cardiometabolic ...
Caloric restriction alters the metabolic response to a mixed-meal: results from a randomized, controlled trial.
(PLoS One, 2012)
OBJECTIVES: To determine if caloric restriction (CR) would cause changes in plasma
metabolic intermediates in response to a mixed meal, suggestive of changes in the
capacity to adapt fuel oxidation to fuel availability or ...
Critical appraisal of four IL-6 immunoassays.
(PLoS One, 2012)
BACKGROUND: Interleukin-6 (IL-6) contributes to numerous inflammatory, metabolic,
and physiologic pathways of disease. We evaluated four IL-6 immunoassays in order
to identify a reliable assay for studies of metabolic and ...
Exercise-induced changes in metabolic intermediates, hormones, and inflammatory markers associated with improvements in insulin sensitivity.
(Diabetes Care, 2011-01)
OBJECTIVE: To understand relationships between exercise training-mediated improvements
in insulin sensitivity (S(I)) and changes in circulating concentrations of metabolic
intermediates, hormones, and inflammatory mediators. ...